Literature DB >> 11123228

Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats.

D Stilli1, A Sgoifo, E Macchi, M Zaniboni, S De Iasio, E Cerbai, A Mugelli, C Lagrasta, G Olivetti, E Musso.   

Abstract

In 47 male adult Wistar rats with 4-wk aortic coarctation (AC) and 39 age-matched sham-operated rats (SO) chronically instrumented for telemetry electrocardiogram recording, we investigated the mechanisms of arrhythmogenesis in moderate cardiac hypertrophy, with an approach from "in vivo" toward the cellular level, analyzing 1) stress-induced cardiac arrhythmias in all rats and 2) myocardial fibrosis in 35 animals and action potential duration and density of hyperpolarization-activated current in 19 others at the ventricular level. Aortic banding increased arterial blood pressure, cardiac weight, and ventricular myocyte volume by 11, 25, and 14%, respectively (P < 0.001-0.05). Ventricular arrhythmias occurred at similar rates in AC and SO rats throughout the stress procedure. Action potential duration and hyperpolarization-activated current were about twice as great and myocardial fibrosis about four times greater in AC animals (P < 0.005-0.05). Electrocardiogram data also revealed more supraventricular arrhythmias in AC rats during the baseline period and after stress and fewer atrioventricular block episodes after stress (P < 0.05). Thus stress-induced supraventricular and atrioventricular nodal, but not ventricular, arrhythmias were affected in moderate cardiac hypertrophy when ventricular morphofunctional alterations were evident.

Entities:  

Mesh:

Year:  2001        PMID: 11123228     DOI: 10.1152/ajpheart.2001.280.1.H142

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  12 in total

Review 1.  HCN channels in the heart: lessons from mouse mutants.

Authors:  S Herrmann; F Hofmann; J Stieber; A Ludwig
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  I K1 and I f in ventricular myocytes isolated from control and hypertrophied rat hearts.

Authors:  María Fernández-Velasco; Gema Ruiz-Hurtado; Carmen Delgado
Journal:  Pflugers Arch       Date:  2006-01-05       Impact factor: 3.657

3.  Effect of input resistance voltage-dependency on DC estimate of membrane capacitance in cardiac myocytes.

Authors:  M Zaniboni; F Cacciani; M Groppi
Journal:  Biophys J       Date:  2005-07-01       Impact factor: 4.033

4.  Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts.

Authors:  María Fernández-Velasco; Nora Goren; Gemma Benito; Javier Blanco-Rivero; Lisardo Boscá; Carmen Delgado
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

Review 5.  Pathophysiology of HCN channels.

Authors:  Stefan Herrmann; Juliane Stieber; Andreas Ludwig
Journal:  Pflugers Arch       Date:  2007-02-14       Impact factor: 3.657

6.  Effects of ischemic preconditioning on ischemia/reperfusion-induced arrhythmias by upregulatation of connexin 43 expression.

Authors:  Zhenguang Chen; Honghe Luo; Mei Zhuang; Lie Cai; Chunhua Su; Yiyan Lei; Jianyong Zou
Journal:  J Cardiothorac Surg       Date:  2011-06-02       Impact factor: 1.637

Review 7.  HCN channels--modulators of cardiac and neuronal excitability.

Authors:  Stefan Herrmann; Sabine Schnorr; Andreas Ludwig
Journal:  Int J Mol Sci       Date:  2015-01-08       Impact factor: 5.923

8.  Ivabradine in Cardiovascular Disease: Heart Rate Isn't Everything.

Authors:  Arthur M Feldman
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

9.  Dysfunctional Hyperpolarization-Activated Cyclic Nucleotide-gated Ion Channels in Cardiac Diseases.

Authors:  Xiaoqi Zhao; Tianxiang Gu
Journal:  Braz J Cardiovasc Surg       Date:  2016-04

10.  Isoform dependent regulation of human HCN channels by cholesterol.

Authors:  Oliver Fürst; Nazzareno D'Avanzo
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.